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Background: In Denmark, the first standalone supervised injecting facility (SIF) opened in Copenhagen’s Vesterbro
neighborhood on October 1, 2012. The purpose of this study was to assess whether use of services provided by the
recently opened SIF was associated with changes in injecting behavior and syringe disposal practices among
people who inject drugs (PWID). We hypothesized that risk behaviors (e.g., syringe sharing), and unsafe syringe
disposal (e.g., dropping used equipment on the ground) had decreased among PWID utilizing the SIF.
Methods: Between February and August of 2013, we conducted interviews using a survey (in English and Danish)
with forty-one people who reported injecting drugs at the SIF. We used descriptive statistics and McNemar’s test to
examine sociodemographic characteristics of the sample, current drugs used, sites of syringe disposal before and
after opening of the SIF, and perceived behavior change since using the SIF.
Results: Of the interviewed participants, 90.2% were male and the majority were younger than 40 years old (60.9%).
Three-quarters (75.6%) of participants reported reductions in injection risk behaviors since the opening of the SIF,
such as injecting in a less rushed manner (63.4%), fewer outdoor injections (56.1%), no longer syringe sharing
(53.7%), and cleaning injecting site(s) more often (43.9%). Approximately two-thirds (65.9%) of participants did not
feel that their frequency of injecting had changed; five participants (12.2%) reported a decrease in injecting frequency,
and only two participants (4.9%) reported an increase in injecting frequency. Twenty-four (58.5%) individuals reported
changing their syringe disposal practices since the opening of the SIF; of those, twenty-three (95.8%) reported changing
from not always disposing safely to always disposing safely (McNemar’s test p-value < 0.001).
Conclusions: Our findings suggest that use of the Copenhagen SIF is associated with adoption of safer behaviors that
reduce harm and promote health among PWID, as well as practices that benefit the Vesterbro neighborhood (i.e., safer
syringe disposal). As a public health intervention, Copenhagen’s SIF has successfully reached PWID engaging in risk
behavior. To fully characterize the impacts of this and other Danish SIFs, further research should replicate this study
with a larger sample size and prospective follow-up.
Keywords: Supervised injecting facility, Drug consumption room, People who inject drugs, Injection drug users, Harm
reduction, Risk behaviors, Syringe disposal, Denmark* Correspondence: Elizabeth_Kinnard@brown.edu
1Department of Behavioral and Social Sciences, Brown University School of
Public Health, 121 South Main Street, Box G-S-121-4, Providence, RI 02912,
USA
Full list of author information is available at the end of the article
© 2014 Kinnard et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Kinnard et al. Harm Reduction Journal 2014, 11:29 Page 2 of 8
http://www.harmreductionjournal.com/content/11/1/29Background
Supervised, or safer, injecting facilities (SIFs) — also
known as supervised injecting rooms (SIRs), supervised
injecting sites (SISs), and drug consumption rooms
(DCRs) — have historically been implemented in re-
sponse to public health and safety concerns that arise
from street-based injecting in urban areas [1]. The pri-
mary objectives of SIFs are to reduce morbidity and
mortality that would otherwise occur from syringe shar-
ing, public injecting, and other activities [1], specifically
infectious disease transmission and fatal overdose, and
to connect people who inject drugs (PWID) to various
health and social programs. These facilities are often
viewed as complementing other harm reduction inter-
ventions [2], by allowing for the consumption of pre-
obtained illicit substances in the most hygienic way pos-
sible under the supervision of healthcare professionals
(e.g., nurses), and thus resulting in improved health and
social equity for PWID [3,4].
SIFs around the world typically provide a calm, well-
lit, health-oriented venue to inject, as well as access to
clean injecting equipment, referrals to external services,
and emergency assistance in the event of an overdose.
Some SIFs are highly comprehensive in their approach
[2,5], providing a host of medical, legal, and social ser-
vices, such as extensive counseling, subsidized food,
showers, lockers, and laundry services [1,2,4-6]. Overall,
by addressing addiction as a chronic, relapsing health
condition, SIFs have been found to reduce barriers to
accessing health-centered care for PWID [7-11].
Beyond promoting the health of PWID, SIFs have also
proven beneficial for the larger communities surround-
ing them. Municipalities that have implemented SIFs
have seen reduced rates of drug injection in public
spaces, reduced burden of illegal drug use on the com-
munity, and expanded opportunities to work with PWID
[2,12,13]. Specifically, results from Sydney, Australia and
Vancouver, Canada have shown reduced public injecting
and discarded needles, as well as decreased drug over-
dose mortality rates in neighborhoods in which SIFs are
located [11,13-18]. Moreover, the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA) has
published two comprehensive reports on SIFs, conclud-
ing that they reach and are accepted by vulnerable target
populations, reduce high-risk drug using behavior, pre-
vent drug use in open spaces and related public disorder,
and improve the health of PWID, and are thus recom-
mended as part of local public health strategies [3,14,19].
Gaining broad-based community support for SIFs is
frequently a key component of implementing these in-
terventions [2]. This was true in Denmark, where there
existed a clear need to reduce mortality rates among
PWID, and to reduce public injecting and discarded
paraphernalia [20-22]. In September 2011, Fixerum, anongovernmental organization (NGO), opened a mobile
SIF in Copenhagen, which provided services for PWID
without police or government interference for ten months
[14]. In June 2012, the Danish parliament adopted a new
amendment (Executive order no. 606) to an existing law
on psychoactive substances that gave municipalities a legal
mandate allowing them to implement and operate standa-
lone SIFs, with permission from the Minister of Health
[14,23]. The Danish parliament included language in the
new law that instructed police and prosecutors not to
search, seize, and prosecute users who were in possession
of “small quantities” of controlled substances for personal
use “in and nearby” SIFs [24]. Copenhagen’s first standa-
lone (non-mobile) SIF was subsequently established on
October 1, 2012 in the Vesterbro neighborhood, where
drug dealing and public injection drug use have historic-
ally been concentrated [20,25]. Users of the SIF are re-
stricted to injecting inside the facility, but clients are
permitted to smoke or sniff illicit drugs in the designated
outside area; thus, Danes often refer to the greater health
facility as a more all-encompassing drug consumption
room (DCR) [26].
To date, no peer-reviewed article evaluating behaviors
and practices among PWID accessing the Copenhagen
SIF, and how the facility may affect the greater Vesterbro
community, has been published. However, Mændenes
Hjem (the Men’s Home) in Copenhagen has conducted
a survey administered among users of the SIF to investi-
gate their experiences and satisfaction with the facility
[27]. The purpose of our study was to assess whether
use of the services provided by the recently opened SIF
in Copenhagen was associated with changes in injecting
behavior and syringe disposal practices among PWID.
We hypothesized that risk behaviors (e.g., syringe shar-
ing), and unsafe syringe disposal (e.g., dropping used




Members of our research team approached individuals
seated in the outdoor area adjacent to the SIF to ask if
they would be willing to take part in a study regarding
their use of SIF services. Due to a limited timeframe for
primary data collection in Copenhagen, convenience sam-
pling approaches were employed. Eligible persons were
those who reported having injected drugs at the SIF in
Copenhagen, Denmark at least once since its opening on
October 1, 2012. Participants were excluded if they only
used drugs at the Copenhagen SIF via routes of adminis-
tration other than injecting (i.e. snorting, smoking, etc.).
Individuals who were eligible and agreed to participate in
the study were asked to complete a survey aimed at gain-
ing insight into injecting behaviors and syringe disposal
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dividuals who completed the survey were asked to refer
their acquaintances who also used the SIF for study
participation. All interviews were conducted between
February and August of 2013.
Survey measures and administration
Participants completed a structural behavioral survey in
Danish or English, and either self-administered the sur-
vey or were interviewed by a member of the research
team. If participants chose to self-administer the survey,
a research assistant was available to answer any ques-
tions. All interviews were completed in person at the
SIF, directly outside the building in an adjacent sitting
area. Privacy during the interview sessions was ensured
to the greatest extent possible by sitting in a secluded
section of the outdoor seating area. At any point, partici-
pants could choose to skip a question or terminate the
interview. Participants were given consent forms explain-
ing the goals of the study, with contact information for the
project supervisor at Brown University.
The survey included questions about sociodemo-
graphic characteristics, current drugs used, most com-
mon sites of injecting, frequency of use at the SIF,
quality of relationships with the community and the
police, as well as other activities and behaviors (e.g.,
overdose). We assessed the presence and absence of
injecting risk behaviors such as rushed/stressful inject-
ing, outdoor injecting, needle and syringe sharing, clean-
ing injection site(s), difficulty in finding a vein, reusing
one’s own needles/syringes, using clean water to inject,
and requiring assistance injecting. Specifically, we asked
participants whether they felt they had changed any of
their reported injecting behaviors that they practiced be-
fore using the SIF. Finally, participants were also asked
whether they felt their frequency of injecting had chan-
ged since using the SIF.
We also assessed primary sites of syringe disposal be-
fore and after the opening of the SIF to determine
whether use of the SIF was associated with safer syringe
disposal methods. Specifically, if participants endorsed
one or more of the following choices when asked about
primary sites of syringe disposal — returned them (sy-
ringes) to the needle exchange (or SIF), put them in my
own sharps container, or put them in an outdoor sharps
container — they were coded as “always safe”. If they
endorsed any of the following choices — threw them in
the garbage, dropped them on the ground, gave them to
another user, flushed them down the toilet, or other —
they were coded as “not always safe.” This method of
coding was used to produce two dichotomous variables —
which indicated “always safe” vs. “not always safe” before
the opening of the SIF, and “always safe” vs. “not always
safe” after the opening of the SIF.Statistical analysis
Descriptive statistics were used to examine demographic
characteristics of the sample, current drugs used, enroll-
ment in treatment in the last six months, frequency of
use at the SIF, and primary site(s) of injecting before the
SIF opened. Next, sites of syringe disposal before and
after the opening of the SIF were compared to assess
whether participants’ primary sites of syringe disposal
changed following the facility’s opening. McNemar’s test
was used to assess whether participants who reported
changing their syringe disposal practices were signifi-
cantly more likely to change from “not always safe” to
“always safe” after the SIF’s opening. Finally, we evalu-
ated perceived behavior change and perceived frequency
change using descriptive statistics. All p-values are two-
sided at α = 0.05, and all analyses were conducted in
SPSS (version 22.0).
This research was conducted as part of a Global Inde-
pendent Study Project (GLISP) through Brown University.
Based on Brown University’s Human Research Protection
Program Policy and Procedure Manual, Section 11, (http://
www.brown.edu/research/human-research-protection-
program-policy-and-procedure-manual-section-11), this
research project did not meet the definition of research
(i.e. the data collected was part of an undergraduate pro-
ject and did not receive external funding), and therefore
IRB review was not required. At no point during the
study was personally identifiable information collected, and
surveys were kept strictly anonymous and confidential.
Results
As shown in Table 1, of the 41 eligible and interviewed
participants, 37 (90.2%) were male, and the median age
of participants was 37 years old (25th; 75th percentiles =
30; 43). A total of 33 participants (80.5%) were born in
Denmark, while the remaining 8 (19.5%) were born
abroad. When asked about their current housing situ-
ation, 11 participants (26.8%) reported being homeless,
12 (29.3%) had temporary housing, and 18 (43.9%) re-
sided in a permanent residence. The median age of first
injection was 18 years old (17; 22). Seventeen partici-
pants (41.5%) had been arrested or charged with a crime
in the past six months.
Also shown in Table 1, cocaine was the most fre-
quently used drug at the SIF, reported by 30 participants
(73.2%), followed by heroin, reported by 25 participants
(61.0%). Twenty-four participants (58.5%) reported any
enrollment in substance abuse treatment in the last six
months. The primary injecting location before the SIF
opened was outdoors (e.g. street, park, parking lot), re-
ported by 25 participants (61.0%), followed by their own
dwelling (56.1%). Since the SIF opened, the majority of
participants (61.0%) reported using the facility at least
once a week.
Table 1 Characteristics and drug use behaviors reported
by a sample of people who inject drugs at a supervised
injecting facility in Copenhagen, Denmark (n = 41)
Characteristic n (%)b
Age (median, 25th; 75th) 37 (30; 43)
22 – 30 11 (26.8)
31 – 40 14 (34.1)
41 – 49 13 (31.7)











Age of first injection (median, 25th; 75th) 18 (17; 22)
12 – 17 16 (39.0)
18 – 23 17 (41.5)
24 – 29 4 (9.8)
30 – 43 4 (9.8)








Any substance abuse treatment 24 (58.5)
Opioid replacement therapy 20 (48.8)
24 hour treatment 3 (7.3)
Other 6 (14.6)
Frequency of use at SIFa
Every day 12 (29.3)
Every couple of days 10 (24.4)
Once a week 3 (7.3)
Every couple of weeks 5 (12.2)
Once a month 3 (7.3)




Table 1 Characteristics and drug use behaviors reported
by a sample of people who inject drugs at a supervised
injecting facility in Copenhagen, Denmark (n = 41)
(Continued)
Primary site of fixing before SIF
Outdoors (street, park, lot, etc.) 25 (61.0)
Own place 23 (56.1)
Other’s place 16 (39.0)
Public washroom 16 (39.0)
Other 2 (4.9)
Note: n’s do not sum to 41 and proportions do not sum to 100% due to
missing values or the possibility of endorsement of more than one option for
some questions.
Note: all data collected between February and August, 2013.
a= refers to activities or behaviors in the last 6 months.
b= n (%) unless otherwise specified.
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ported disposing of their used syringes by returning them
to the needle exchange or SIF increased from 14 partici-
pants (34.1%) before the SIF opened to 36 participants
(87.8%) after the SIF opened. The only unsafe disposal
method that was still reported by participants after the
opening of the SIF was throwing syringes in the garbage,
but this behavior decreased from 23 participants (56.1%)
before to 5 participants (12.2%) after the opening of the
SIF. All other unsafe methods (i.e. dropped them on the
ground, gave them to another user, flushed them down
the toilet, or other) were reported infrequently before the
SIF opened, but were not reported by any participant after
the SIF opened. In total, twenty-four individuals (58.5%)
reported changing their syringe disposal practices follow-
ing the opening of the SIF; of those, twenty-three (95.8%)
reported changing from not always disposing safely toTable 2 Primary locations for disposal of used syringes
among a sample of people who inject drugs before and
after the opening of a supervised injecting facility in
Copenhagen, Denmark (n = 41)




Returned to the needle exchange
(or SIF)
14 (34.1) 36 (87.8)
Put them in an outdoors sharps
container
19 (46.3) 8 (19.5)
Put them in their own sharps container 11 (26.8) 6 (14.6)
Threw them in the garbage 23 (56.1) 5 (12.2)
Dropped them on the ground 5 (12.2) 0 (0.0)
Gave them to another user 2 (4.9) 0 (0.0)
Flushed them down the toilet 4 (9.8) 0 (0.0)
Other 3 (7.3) 0 (0.0)
Note: n’s do not sum to 41 and proportions do not sum to 100% because
participants may have identified more than one location as primary site of
used syringe disposal.
Note: all data collected between February and August, 2013.
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only one individual (4.2%) reported the reverse behavior.
As shown in Table 3, 31 individuals (75.6%) believed
their behaviors had changed since utilizing the services
at the SIF. As compared with their behaviors before the
SIF opened, 26 participants (63.4%) reported less rushed/
stressful injections, 23 participants (56.1%) reported less
injecting outdoors, 22 participants (53.7%) reported no
longer sharing needles, and 18 participants (43.9%) re-
ported cleaning the injecting site on their skin more often.
Other types of behavior change reported by participants
are shown in Table 3. The majority (65.9%) did not feel
that their frequency of injecting had changed; however,
five participants (12.2%) reported a decrease in injecting
frequency, while only two participants (4.9%) reported an
increase in injecting frequency.Discussion
Our results from interviews with a small sample of PWID
suggest that use of the SIF in Copenhagen was associated
with positive self-reported behavior change and safer syr-
inge disposal practices. Given that the majority of partici-
pants reported unstable housing and outdoor injecting
before the SIF opened, we conclude that the SIF has been
successful in engaging a hard-to-reach population that
would otherwise inject primarily outdoors in the Vesterbro
area. Furthermore, the majority of participants (61.0%) re-
ported using the SIF at least once a week, which demon-
strates that the SIF can serve as a low-threshold healthTable 3 Perceived behavior and frequency change among a
sample of people who inject drugs at a supervised injecting
facility since its opening in Copenhagen, Denmark (n = 41)
Characteristic n (%)
Any perceived behavior change 31 (75.6)
Less rushed/stressful 26 (63.4)
Less injecting outdoors 23 (56.1)
No longer share needles 22 (53.7)
Clean injection site more often 18 (43.9)
Easier to get vein first time 16 (39.0)
Reuse own needles less often 11 (26.8)
Use clean water more often 11 (26.8)
No longer need help injecting 6 (14.6)
Other 3 (7.3)
Perceived frequency change
No change 27 (65.9)
Decreased (inject less often) 5 (12.2)
Increased (inject more often) 2 (4.9)
Unsure 4 (9.8)
Note: n’s do not sum to 41 and proportions do not sum to 100% due to
missing values or where participants endorsed more than one option.
Note: all data collected between February and August, 2013.service to engage PWID [27]. Finally, our results suggest
that the SIF fills an important gap of other harm reduction
interventions in Copenhagen, which do not engage PWID
beyond provision of injecting equipment [2].
Three-quarters of our sample believed their behaviors
had changed since using the SIF, such as injecting in a
less rushed manner, injecting outdoors less often, no
longer syringe sharing, and cleaning injecting site(s)
more often. Of particular interest is the reduction in
public injecting, known to be associated with an elevated
risk of blood-borne virus acquisition [28] and overdose
[29,30]. Injecting in public (and in other settings in
which maintaining a hygienic drug-using environment is
difficult), has also been associated with vascular harm
and bacterial infection [31-33]. By providing a nonjudg-
mental, low-threshold venue, (i.e. use of SIF services re-
quires little bureaucracy, no payment, and is not linked
to an obligation of the client to be or to become drug-
free) [34] for PWID to consume pre-obtained substances,
the Copenhagen SIF has the potential to significantly
lower the frequency of deleterious injecting episodes for
local drug users. Overall, our finding that users of the SIF
have reported a reduction in public injecting, as well as a
reduction in publicly discarded syringes, supports the
harm reduction framework and goals that the SIF aimed
to achieve [30,31].
Our study adds to the SIF literature, which consists of
many reports showing that public drug use has declined
since the implementation of SIFs in Vancouver, Sydney,
and multiple western European cities [11,13,15,17,18,35-39],
as well as reports of fewer discarded syringes found in all
Swiss cities that have implemented SIFs [2,14,40].
Finally, we found associations between use of the SIF
and decreased equipment sharing, as well as improved
injecting hygiene and technique, in accordance with the
existing literature [31,35,41-43]. There was no evidence
that use of the SIF significantly changed self-reported
injecting frequency. This supports previous research
demonstrating that SIFs do not result in increased
injecting frequency among PWID accessing such facil-
ities [44,45]. We conclude that, overall, utilization of the
SIF has resulted in positive behavior change toward
healthier injecting hygiene and reduced risk of blood-
borne disease transmission among study participants.
Regarding the capacity of the facility, findings from the
Men’s Home’s survey found that approximately 22% of
reported injections take place in the users' own homes,
and 22% still in the public domain [27]. According to
our data, before the SIF opened, 61% of injections took
place in the public domain (outdoors) and 56.1% in
users’ own homes. Although we did not ask specifically
about primary locations of injecting after the opening of
the SIF, 56.1% of our sample reported injecting outdoors
less frequently. The capacity of the current SIF to
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an important finding [27]. Aside from the sheer numbers
of injections that the SIF can accommodate, the interviews
from the Men’s Home indicate that users choose the SIF
for their drug consumption rather than elsewhere because
of the security in knowing that there is a health profes-
sional to help them should they require medical attention
for an overdose or other health issue. Since the data col-
lection phase of both studies, an additional drug con-
sumption room, “Skyen”, or “The Cloud”, has opened
nearby in The Men’s Home itself, which can seat eight in-
dividuals for injecting and six for smoking, augmenting
the overall capacity of SIFs in Copenhagen [27,46].
To assess whether we reached a sample of PWID simi-
lar to that of the Men’s Home’s study, we compared
sociodemographic characteristics across the two studies
[27]. Their questionnaire, administered in spring 2013,
was answered by 56 newly registered users. Their sample
comprised 30% female users, while our sample com-
prises 10% females. Thus, it appears that women may be
under-represented in our study. However, the age distri-
bution of the two samples are similar: the participants of
the Men’s Home survey were between 22 and 53 years,
with a mean age of 38 years, while the ages in our sam-
ple spanned 22 years to 57 years, with the mean age at
37 years. We also note that the Men’s Home’s sample
comprised a very frequent group of users; nearly half of
survey participants presented at the SIF several times a
day. Our survey also captured frequent users, as over
half came every day or a few times a week, although we
also captured infrequent users, as 20% reported coming
once a month or less.
One of the primary limitations of our study is a small
sample size and limited power to conduct bivariable stat-
istical tests. Further research with a larger sample size is
recommended to confirm the observed findings. More-
over, convenience sampling approaches, which were
used in this study to recruit participants who presented
at the SIF, may prevent generalization to a wider drug-
using population in Denmark. As the registry of users at
the SIF is completely anonymous, there was no avail-
able sampling frame from which to draw for this study.
Now that Denmark has implemented additional SIFs in
Copenhagen and other cities, it would be beneficial for
public health professionals to conduct a multisite study
to examine how PWID’s demographics vary among the
sites, or how particular programmatic elements of each
site have proven successful or unsuccessful.
Our study is subject to a number of additional limita-
tions. First, we relied on self-reported behavior change
assessed at one point in time, rather than measuring
these variables prospectively at multiple time points,
which could introduce bias due to measurement error.
The cross-sectional structured behavioral survey alsodoes not allow for inferences about temporal associa-
tions and causal pathways between measured factors.
However, as our questions were posed in a way that
asked about behaviors before and after the opening of
the SIF, we believe that our conclusions regarding the
association between use of the SIF and behavior change
have merit. Second, this study only assessed the short-
term effect of the SIF; thus, additional studies should
aim to assess longer-term impact on the health behav-
iors of PWID. Third, a further limitation of our study re-
lates to the sociodemographic characteristics of the
sample (e.g., comprised predominately of men). Thus,
our results are not entirely representative and may not
capture the true lived experiences and behavior changes
of women who use the SIF.
Fourth, the survey instrument was not delivered uni-
formly to all participants; the survey was either self-
administered or read aloud by a research assistant, and
delivered in either English or Danish. Some members of
our research team were not bilingual in English and
Danish, and participants may have opted to have the
survey read aloud in English even though their primary
language was Danish, which could have led to misinter-
pretations and misreporting of personal information and
behavior change. It is therefore possible that some be-
haviors could be under-reported, over-reported, or mis-
reported. Finally, ascertainment of stigmatized behaviors
might have introduced social desirability biases, espe-
cially when research assistants read the survey items
aloud. This may have been mitigated by providing par-
ticipants with the opportunity to self-administer the
survey, an option they would have most likely chosen
had they felt the questions were too sensitive or stig-
matizing [47].
Conclusions
Our findings indicate that utilization of services pro-
vided by the first standalone SIF in Copenhagen is asso-
ciated with self-reported adoption of safer behaviors that
reduce harm and promote health among people who
inject drugs (e.g., less rushed/stressful injections, less
injecting outdoors, and no longer sharing needles). Use
of the SIF was also associated with changes in practices
that benefit the Vesterbro neighborhood (i.e., safer syr-
inge disposal). As a public health intervention, the SIF in
Copenhagen has successfully reached PWID engaging in
high-risk behavior, has not led to an increase in overall
frequency of injecting, and has resulted in benefits for
the greater community. Since the data collection phase
of this study, there have been additional SIFs imple-
mented in Copenhagen and across Denmark, which
merit their own research and evaluation. However, this
pilot peer-reviewed evaluation provides the first evidence
that the expansion of Danish SIFs is likely a positive,
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cial equity for people who inject drugs.
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